Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
E4BP4-mediated inhibition of T follicular helper cell differentiation is compromised in autoimmune diseases
Zijun Wang, … , Akihiko Yoshimura, Qianjin Lu
Zijun Wang, … , Akihiko Yoshimura, Qianjin Lu
Published March 19, 2020
Citation Information: J Clin Invest. 2020;130(7):3717-3733. https://doi.org/10.1172/JCI129018.
View: Text | PDF
Research Article Autoimmunity

E4BP4-mediated inhibition of T follicular helper cell differentiation is compromised in autoimmune diseases

  • Text
  • PDF
Abstract

T follicular helper (Tfh) cells are indispensable for the formation of germinal center (GC) reactions, whereas T follicular regulatory (Tfr) cells inhibit Tfh-mediated GC responses. Aberrant activation of Tfh cells contributes substantially to the pathogenesis of autoimmune diseases, such as systemic lupus erythematosus (SLE). Nonetheless, the molecular mechanisms mitigating excessive Tfh cell differentiation are not fully understood. Herein we demonstrate that the adenovirus E4 promoter-binding protein (E4BP4) mediates a feedback loop and acts as a transcriptional brake to inhibit Tfh cell differentiation. Furthermore, we show that such an immunological mechanism is compromised in patients with SLE. Establishing mice with either conditional knockout (cKO) or knockin (cKI) of the E4bp4 gene in T cells reveals that E4BP4 strongly inhibits Tfh cell differentiation. Mechanistically, E4BP4 regulates Bcl6 transcription by recruiting the repressive epigenetic modifiers HDAC1 and EZH2. E4BP4 phosphorylation site mutants have limited capability with regard to inhibiting Tfh cell differentiation. In SLE, we detected impaired phosphorylation of E4BP4, finding that this compromised transcription factor is positively correlated with disease activity. These findings unveiled molecular mechanisms by which E4BP4 restrains Tfh cell differentiation, whose compromised function is associated with uncontrolled autoimmune reactions in SLE.

Authors

Zijun Wang, Ming Zhao, Jinghua Yin, Limin Liu, Longyuan Hu, Yi Huang, Aiyun Liu, Jiajun Ouyang, Xiaoli Min, Shijia Rao, Wenhui Zhou, Haijing Wu, Akihiko Yoshimura, Qianjin Lu

×

Figure 6

E4BP4 regulates Tfh cell differentiation by binding to the Bcl6 promoter.

Options: View larger image (or click on image) Download as PowerPoint
E4BP4 regulates Tfh cell differentiation by binding to the Bcl6 promoter...
(A) Venn diagram showing the overlap between the genes with E4BP4 enrichment in promoter (green) and differentially expressed genes revealed by expression profile analysis (yellow). (B) ChIP-Seq analysis of E4BP4-binding peaks located at gene loci Bcl6 and Il13 in the E4bp4-cKI CD4+ T cells. The Bcl6-binding site motif is shown (right). (C–F) E4bp4-cKI/E4bp4-cKO naive CD4+ T cells were cultured under Tfh-polarizing conditions for 5 days. (C) ChIP-PCR was performed with IgG and anti-FLAG antibody to analyze the binding activity of E4BP4 to Bcl6. (D) The H3 acetylation and H3K27 trimethylation levels in the Bcl6 promoter region in WT versus E4bp4-cKI mice are shown. (E) The H3 acetylation and H3K27 trimethylation levels in the Bcl6 promoter region in WT versus E4bp4-cKO mice are shown. (F) The enrichments of HDAC1 and EZH2 in the Bcl6 promoter region in WT versus E4bp4-cKO mice are shown (n = 3). (G–I) Anti-FLAG antibody, anti-HDAC1, and anti-EZH2 antibodies were used for coimmunoprecipitation experiments to analyze the interaction between E4BP4 and HDAC1 or EZH2 in E4bp4-cKI Tfh-like cells. Each result corresponds to data pooled from 3 independent experiments. Student’s t test. ***P < 0.001; **P < 0.01; *P < 0.05.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts